文献速递中医内科中药与中成药合理使用

中医药在脓毒症危重症管理中的应用综述

Application of Chinese Medicine in the Management of Critical Conditions: A Review on Sepsis.
PubMed 文献 · Am J Chin Med · 2020-09-09

脓毒症是ICU主要死亡原因,标准治疗存在抗菌药物耐药、糖皮质激素使用争议、ICU住院时间长及费用高等问题。本文综述中药复方、单味药及分离化合物作为标准西医治疗附加疗法在脓毒症管理中的应用现状,强调通过清热解毒、活血化瘀、增强胃肠功能及扶正来平衡感染免疫反应,并指出在COVID-19大流行背景下辅助中药治疗可用于ICU危重症患者。

要点

  • 中药作为标准西医治疗的附加疗法用于脓毒症管理。
  • 中药应用强调调和感染免疫反应,含清热解毒、活血化瘀、增强胃肠功能及扶正。
  • COVID-19大流行背景下辅助中药治疗可用于ICU危重症患者。

核心结论

  • 中药复方、单味药及分离化合物作为标准西医治疗的附加疗法在脓毒症管理中应用日益增多。
  • 辅助中药治疗可在ICU用于治疗感染新型冠状病毒的危重症患者。

研究设计与样本

  • 综述,概述中药复方、单味药及分离化合物作为标准西医治疗附加疗法在脓毒症管理中的应用现状。

主要发现

  • 脓毒症是ICU主要死亡原因,标准治疗存在抗菌药物耐药、糖皮质激素使用争议、ICU住院时间长及治疗费用高等未解决问题。
  • 中药应用强调使用中药复方平衡对感染的免疫反应,包括清热解毒、活血化瘀、增强胃肠功能及扶正。

临床怎么用

  • 在脓毒症管理中可将中药复方、单味药或分离化合物作为标准西医治疗的附加疗法。
  • 在COVID-19大流行背景下,ICU可考虑辅助中药治疗感染新型冠状病毒的危重症患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Critical care medicine is a medical specialty engaging the diagnosis and treatment of critically ill patients who have or are likely to have life-threatening organ failure. Sepsis, a life-threatening condition that arises when the body responds to infection, is currently the major cause of death in intensive care units (ICU). Although progress has been made in understanding the pathophysiology of sepsis, many drawbacks in sepsis treatment remains unresolved. For example, antimicrobial resistance, controversial of glucocorticoids use, prolonged duration of ICU care and the subsequent high cost of the treatment. Recent years have witnessed a growing trend of applying traditional Chinese medicine (TCM) in sepsis management. The TCM application emphasizes use of herbal formulation to balance immune responses to infection, which include clearing heat and toxin, promoting blood circulation and removing its stasis, enhancing gastrointestinal function, and strengthening body resistance. In this paper, we will provide an overview of the current status of Chinese herbal formulations, single herbs, and isolated compounds, as an add-on therapy to the standard Western treatment in the sepsis management. With the current trajectory of worldwide pandemic eruption of newly identified Coronavirus Disease-2019 (COVID-19), the adjuvant TCM therapy can be used in the ICU to treat critically ill patients infected with the novel coronavirus.

来源:Am J Chin Med,查看原文。版权归原作者所有。

引用

  1. Fan TT, Cheng BL, Fang XM, et al. Application of Chinese Medicine in the Management of Critical Conditions: A Review on Sepsis. Am J Chin Med. 2020. PMID: 32907362. doi:10.1142/S0192415X20500640

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。